1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Vitamin E and Pioglitazone 1.2.3 Ocaliva 1.2.4 Elafibranor 1.2.5 Selonsertib and Cenicriviroc 1.3 Market by Application 1.3.1 Global NASH Therapeutic Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacy 1.3.3 Online Provider 1.3.4 Retail Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global NASH Therapeutic Drugs Market Perspective (2016-2027) 2.2 NASH Therapeutic Drugs Growth Trends by Regions 2.2.1 NASH Therapeutic Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 NASH Therapeutic Drugs Historic Market Share by Regions (2016-2021) 2.2.3 NASH Therapeutic Drugs Forecasted Market Size by Regions (2022-2027) 2.3 NASH Therapeutic Drugs Industry Dynamic 2.3.1 NASH Therapeutic Drugs Market Trends 2.3.2 NASH Therapeutic Drugs Market Drivers 2.3.3 NASH Therapeutic Drugs Market Challenges 2.3.4 NASH Therapeutic Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top NASH Therapeutic Drugs Players by Revenue 3.1.1 Global Top NASH Therapeutic Drugs Players by Revenue (2016-2021) 3.1.2 Global NASH Therapeutic Drugs Revenue Market Share by Players (2016-2021) 3.2 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by NASH Therapeutic Drugs Revenue 3.4 Global NASH Therapeutic Drugs Market Concentration Ratio 3.4.1 Global NASH Therapeutic Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by NASH Therapeutic Drugs Revenue in 2020 3.5 NASH Therapeutic Drugs Key Players Head office and Area Served 3.6 Key Players NASH Therapeutic Drugs Product Solution and Service 3.7 Date of Enter into NASH Therapeutic Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 NASH Therapeutic Drugs Breakdown Data by Type 4.1 Global NASH Therapeutic Drugs Historic Market Size by Type (2016-2021) 4.2 Global NASH Therapeutic Drugs Forecasted Market Size by Type (2022-2027) 5 NASH Therapeutic Drugs Breakdown Data by Application 5.1 Global NASH Therapeutic Drugs Historic Market Size by Application (2016-2021) 5.2 Global NASH Therapeutic Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America NASH Therapeutic Drugs Market Size (2016-2027) 6.2 North America NASH Therapeutic Drugs Market Size by Type 6.2.1 North America NASH Therapeutic Drugs Market Size by Type (2016-2021) 6.2.2 North America NASH Therapeutic Drugs Market Size by Type (2022-2027) 6.2.3 North America NASH Therapeutic Drugs Market Size by Type (2016-2027) 6.3 North America NASH Therapeutic Drugs Market Size by Application 6.3.1 North America NASH Therapeutic Drugs Market Size by Application (2016-2021) 6.3.2 North America NASH Therapeutic Drugs Market Size by Application (2022-2027) 6.3.3 North America NASH Therapeutic Drugs Market Size by Application (2016-2027) 6.4 North America NASH Therapeutic Drugs Market Size by Country 6.4.1 North America NASH Therapeutic Drugs Market Size by Country (2016-2021) 6.4.2 North America NASH Therapeutic Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe NASH Therapeutic Drugs Market Size (2016-2027) 7.2 Europe NASH Therapeutic Drugs Market Size by Type 7.2.1 Europe NASH Therapeutic Drugs Market Size by Type (2016-2021) 7.2.2 Europe NASH Therapeutic Drugs Market Size by Type (2022-2027) 7.2.3 Europe NASH Therapeutic Drugs Market Size by Type (2016-2027) 7.3 Europe NASH Therapeutic Drugs Market Size by Application 7.3.1 Europe NASH Therapeutic Drugs Market Size by Application (2016-2021) 7.3.2 Europe NASH Therapeutic Drugs Market Size by Application (2022-2027) 7.3.3 Europe NASH Therapeutic Drugs Market Size by Application (2016-2027) 7.4 Europe NASH Therapeutic Drugs Market Size by Country 7.4.1 Europe NASH Therapeutic Drugs Market Size by Country (2016-2021) 7.4.2 Europe NASH Therapeutic Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific NASH Therapeutic Drugs Market Size (2016-2027) 8.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Type 8.2.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Application 8.3.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific NASH Therapeutic Drugs Market Size by Region 8.4.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America NASH Therapeutic Drugs Market Size (2016-2027) 9.2 Latin America NASH Therapeutic Drugs Market Size by Type 9.2.1 Latin America NASH Therapeutic Drugs Market Size by Type (2016-2021) 9.2.2 Latin America NASH Therapeutic Drugs Market Size by Type (2022-2027) 9.2.3 Latin America NASH Therapeutic Drugs Market Size by Type (2016-2027) 9.3 Latin America NASH Therapeutic Drugs Market Size by Application 9.3.1 Latin America NASH Therapeutic Drugs Market Size by Application (2016-2021) 9.3.2 Latin America NASH Therapeutic Drugs Market Size by Application (2022-2027) 9.3.3 Latin America NASH Therapeutic Drugs Market Size by Application (2016-2027) 9.4 Latin America NASH Therapeutic Drugs Market Size by Country 9.4.1 Latin America NASH Therapeutic Drugs Market Size by Country (2016-2021) 9.4.2 Latin America NASH Therapeutic Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa NASH Therapeutic Drugs Market Size (2016-2027) 10.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Type 10.2.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Application 10.3.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa NASH Therapeutic Drugs Market Size by Country 10.4.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan Plc (Tobira) 11.1.1 Allergan Plc (Tobira) Company Details 11.1.2 Allergan Plc (Tobira) Business Overview 11.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction 11.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2016-2021) 11.1.5 Allergan Plc (Tobira) Recent Development 11.2 Bristol Myers Squibb 11.2.1 Bristol Myers Squibb Company Details 11.2.2 Bristol Myers Squibb Business Overview 11.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction 11.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2016-2021) 11.2.5 Bristol Myers Squibb Recent Development 11.3 Galmed Pharmaceuticals 11.3.1 Galmed Pharmaceuticals Company Details 11.3.2 Galmed Pharmaceuticals Business Overview 11.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction 11.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2016-2021) 11.3.5 Galmed Pharmaceuticals Recent Development 11.4 Genfit SA 11.4.1 Genfit SA Company Details 11.4.2 Genfit SA Business Overview 11.4.3 Genfit SA NASH Therapeutic Drugs Introduction 11.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2016-2021) 11.4.5 Genfit SA Recent Development 11.5 Gilead Sciences, Inc. 11.5.1 Gilead Sciences, Inc. Company Details 11.5.2 Gilead Sciences, Inc. Business Overview 11.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction 11.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2016-2021) 11.5.5 Gilead Sciences, Inc. Recent Development 11.6 Intercept Pharmaceuticals, Inc. 11.6.1 Intercept Pharmaceuticals, Inc. Company Details 11.6.2 Intercept Pharmaceuticals, Inc. Business Overview 11.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction 11.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2016-2021) 11.6.5 Intercept Pharmaceuticals, Inc. Recent Development 11.7 Zydus Cadila 11.7.1 Zydus Cadila Company Details 11.7.2 Zydus Cadila Business Overview 11.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction 11.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2016-2021) 11.7.5 Zydus Cadila Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global NASH Therapeutic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Vitamin E and Pioglitazone Table 3. Key Players of Ocaliva Table 4. Key Players of Elafibranor Table 5. Key Players of Selonsertib and Cenicriviroc Table 6. Global NASH Therapeutic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global NASH Therapeutic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global NASH Therapeutic Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global NASH Therapeutic Drugs Market Share by Regions (2016-2021) Table 10. Global NASH Therapeutic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global NASH Therapeutic Drugs Market Share by Regions (2022-2027) Table 12. NASH Therapeutic Drugs Market Trends Table 13. NASH Therapeutic Drugs Market Drivers Table 14. NASH Therapeutic Drugs Market Challenges Table 15. NASH Therapeutic Drugs Market Restraints Table 16. Global NASH Therapeutic Drugs Revenue by Players (2016-2021) & (US$ Million) Table 17. Global NASH Therapeutic Drugs Market Share by Players (2016-2021) Table 18. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NASH Therapeutic Drugs as of 2020) Table 19. Ranking of Global Top NASH Therapeutic Drugs Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by NASH Therapeutic Drugs Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players NASH Therapeutic Drugs Product Solution and Service Table 23. Date of Enter into NASH Therapeutic Drugs Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million) Table 26. Global NASH Therapeutic Drugs Revenue Market Share by Type (2016-2021) Table 27. Global NASH Therapeutic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global NASH Therapeutic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global NASH Therapeutic Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global NASH Therapeutic Drugs Revenue Market Share by Application (2016-2021) Table 31. Global NASH Therapeutic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global NASH Therapeutic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million) Table 34. North America NASH Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million) Table 35. North America NASH Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million) Table 36. North America NASH Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million) Table 37. North America NASH Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million) Table 38. North America NASH Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million) Table 40. Europe NASH Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe NASH Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million) Table 42. Europe NASH Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe NASH Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe NASH Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America NASH Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America NASH Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America NASH Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America NASH Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America NASH Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million) Table 63. Allergan Plc (Tobira) Company Details Table 64. Allergan Plc (Tobira) Business Overview Table 65. Allergan Plc (Tobira) NASH Therapeutic Drugs Product Table 66. Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million) Table 67. Allergan Plc (Tobira) Recent Development Table 68. Bristol Myers Squibb Company Details Table 69. Bristol Myers Squibb Business Overview Table 70. Bristol Myers Squibb NASH Therapeutic Drugs Product Table 71. Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million) Table 72. Bristol Myers Squibb Recent Development Table 73. Galmed Pharmaceuticals Company Details Table 74. Galmed Pharmaceuticals Business Overview Table 75. Galmed Pharmaceuticals NASH Therapeutic Drugs Product Table 76. Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million) Table 77. Galmed Pharmaceuticals Recent Development Table 78. Genfit SA Company Details Table 79. Genfit SA Business Overview Table 80. Genfit SA NASH Therapeutic Drugs Product Table 81. Genfit SA Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million) Table 82. Genfit SA Recent Development Table 83. Gilead Sciences, Inc. Company Details Table 84. Gilead Sciences, Inc. Business Overview Table 85. Gilead Sciences, Inc. NASH Therapeutic Drugs Product Table 86. Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million) Table 87. Gilead Sciences, Inc. Recent Development Table 88. Intercept Pharmaceuticals, Inc. Company Details Table 89. Intercept Pharmaceuticals, Inc. Business Overview Table 90. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product Table 91. Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million) Table 92. Intercept Pharmaceuticals, Inc. Recent Development Table 93. Zydus Cadila Company Details Table 94. Zydus Cadila Business Overview Table 95. Zydus Cadila NASH Therapeutic Drugs Product Table 96. Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million) Table 97. Zydus Cadila Recent Development Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Global NASH Therapeutic Drugs Market Share by Type: 2020 VS 2027 Figure 2. Vitamin E and Pioglitazone Features Figure 3. Ocaliva Features Figure 4. Elafibranor Features Figure 5. Selonsertib and Cenicriviroc Features Figure 6. Global NASH Therapeutic Drugs Market Share by Application: 2020 VS 2027 Figure 7. Hospital Pharmacy Case Studies Figure 8. Online Provider Case Studies Figure 9. Retail Pharmacy Case Studies Figure 10. NASH Therapeutic Drugs Report Years Considered Figure 11. Global NASH Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global NASH Therapeutic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global NASH Therapeutic Drugs Market Share by Regions: 2020 VS 2027 Figure 14. Global NASH Therapeutic Drugs Market Share by Regions (2022-2027) Figure 15. Global NASH Therapeutic Drugs Market Share by Players in 2020 Figure 16. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NASH Therapeutic Drugs as of 2020 Figure 17. The Top 10 and 5 Players Market Share by NASH Therapeutic Drugs Revenue in 2020 Figure 18. Global NASH Therapeutic Drugs Revenue Market Share by Type (2016-2021) Figure 19. Global NASH Therapeutic Drugs Revenue Market Share by Type (2022-2027) Figure 20. North America NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America NASH Therapeutic Drugs Market Share by Type (2016-2027) Figure 22. North America NASH Therapeutic Drugs Market Share by Application (2016-2027) Figure 23. North America NASH Therapeutic Drugs Market Share by Country (2016-2027) Figure 24. United States NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe NASH Therapeutic Drugs Market Share by Type (2016-2027) Figure 28. Europe NASH Therapeutic Drugs Market Share by Application (2016-2027) Figure 29. Europe NASH Therapeutic Drugs Market Share by Country (2016-2027) Figure 30. Germany NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific NASH Therapeutic Drugs Market Share by Type (2016-2027) Figure 38. Asia-Pacific NASH Therapeutic Drugs Market Share by Application (2016-2027) Figure 39. Asia-Pacific NASH Therapeutic Drugs Market Share by Region (2016-2027) Figure 40. China NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America NASH Therapeutic Drugs Market Share by Type (2016-2027) Figure 48. Latin America NASH Therapeutic Drugs Market Share by Application (2016-2027) Figure 49. Latin America NASH Therapeutic Drugs Market Share by Country (2016-2027) Figure 50. Mexico NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa NASH Therapeutic Drugs Market Share by Type (2016-2027) Figure 54. Middle East & Africa NASH Therapeutic Drugs Market Share by Application (2016-2027) Figure 55. Middle East & Africa NASH Therapeutic Drugs Market Share by Country (2016-2027) Figure 56. Turkey NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Allergan Plc (Tobira) Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021) Figure 60. Bristol Myers Squibb Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021) Figure 61. Galmed Pharmaceuticals Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021) Figure 62. Genfit SA Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021) Figure 63. Gilead Sciences, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021) Figure 64. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021) Figure 65. Zydus Cadila Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Allergan Plc (Tobira) Bristol Myers Squibb Galmed Pharmaceuticals Genfit SA Gilead Sciences, Inc. Intercept Pharmaceuticals, Inc. Zydus Cadila